Lecap Asset Management Ltd. Acquires 8,707 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Lecap Asset Management Ltd. lifted its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 72.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,662 shares of the medical device company's stock after buying an additional 8,707 shares during the quarter. Lecap Asset Management Ltd.'s holdings in Cooper Companies were worth $1,743,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. OFI Invest Asset Management purchased a new position in Cooper Companies during the fourth quarter valued at $34,000. City Holding Co. bought a new position in shares of Cooper Companies during the first quarter valued at $34,000. New Age Alpha Advisors LLC purchased a new position in shares of Cooper Companies in the 4th quarter worth about $38,000. Covestor Ltd boosted its stake in Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after purchasing an additional 120 shares in the last quarter. Finally, Atala Financial Inc purchased a new stake in Cooper Companies during the 4th quarter valued at about $51,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

COO traded up $1.45 during trading on Friday, hitting $71.14. The company's stock had a trading volume of 5,274,900 shares, compared to its average volume of 1,687,979. The business's 50 day simple moving average is $76.42 and its 200-day simple moving average is $84.13. The firm has a market cap of $14.23 billion, a PE ratio of 34.53, a P/E/G ratio of 1.70 and a beta of 0.98. The Cooper Companies, Inc. has a one year low of $65.00 and a one year high of $112.38. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping analysts' consensus estimates of $0.93 by $0.03. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The company had revenue of $1 billion for the quarter, compared to analysts' expectations of $995.12 million. During the same period last year, the firm earned $0.85 EPS. Cooper Companies's revenue for the quarter was up 6.3% compared to the same quarter last year. As a group, sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Wall Street Zen cut shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, June 7th. Stifel Nicolaus decreased their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. Loop Capital set a $100.00 target price on Cooper Companies in a research report on Tuesday, June 17th. Citigroup reduced their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Finally, Piper Sandler reaffirmed an "overweight" rating and issued a $105.00 target price (down previously from $115.00) on shares of Cooper Companies in a research report on Friday, May 30th. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $99.70.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.